Kura Oncology CEO Troy Wilson's 2018 pay jumps 176% to $4.7M
Kura Oncology reports 2018 executive compensation
By ExecPay News
Published: April 29, 2019
Kura Oncology reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, four executives at Kura Oncology received on average a compensation package of $3M, a 135% increase compared to previous year.
Average pay of disclosed executives at Kura Oncology
Troy E. Wilson, Chief Executive Officer, received $4.7M in total, which increased by 176% compared to 2017. 80% of Wilson's compensation, or $3.8M, was in option awards. Wilson also received $368K in non-equity incentive plan, $526K in salary, as well as $57K in other compensation.
Marc Grasso, Chief Financial Officer, received a compensation package of $3.6M. 90% of the compensation package, or $3.3M, was in option awards.
Antonio Gualberto, Chief Medical Officer, earned $2M in 2018, a 61% increase compared to previous year.
John Farnam, Chief Operating Officer, received $1.7M in 2018.
Related executives
You may also like
Source: SEC filing on April 29, 2019.